• LAST PRICE
    2.4300
  • TODAY'S CHANGE (%)
    Trending Down-0.2700 (-10.0000%)
  • Bid / Lots
    2.3800/ 5
  • Ask / Lots
    2.4900/ 3
  • Open / Previous Close
    2.7300 / 2.7000
  • Day Range
    Low 2.3400
    High 2.7300
  • 52 Week Range
    Low 1.3600
    High 10.4800
  • Volume
    374,655
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.7
TimeVolumePXMD
09:32 ET107822.65
09:33 ET5002.656
09:35 ET8482.62
09:37 ET37202.53
09:39 ET9282.575
09:42 ET13672.57
09:44 ET5602.58
09:46 ET35732.61
09:48 ET16782.5813
09:50 ET14002.585
09:51 ET12502.5817
09:53 ET19102.62
09:55 ET6402.5993
09:57 ET4002.595
10:00 ET33002.5989
10:02 ET51022.59
10:04 ET100832.5765
10:06 ET11002.5643
10:08 ET9002.5503
10:09 ET7002.54
10:11 ET9402.56
10:13 ET55182.6
10:20 ET23972.58
10:22 ET8942.5648
10:24 ET1002.5501
10:26 ET40452.53
10:27 ET3922.53
10:31 ET68632.46
10:33 ET39262.46
10:36 ET32372.5
10:38 ET15002.475
10:42 ET2252.4883
10:44 ET3002.47
10:45 ET30332.4622
10:47 ET34762.48
10:49 ET8012.4729
10:51 ET5002.4767
10:54 ET1002.47
10:56 ET5002.4501
10:58 ET68832.42
11:00 ET180662.34
11:02 ET37392.3756
11:03 ET27242.4167
11:05 ET3002.43
11:07 ET17052.4242
11:09 ET154002.4299
11:14 ET8082.4425
11:16 ET53002.46
11:18 ET2202.49
11:20 ET3182.49
11:21 ET50992.52
11:23 ET4002.5193
11:25 ET12002.53
11:30 ET12002.53
11:32 ET65502.52
11:34 ET121162.5185
11:36 ET25002.51
11:38 ET19102.5097
11:39 ET26332.51
11:41 ET5002.5083
11:45 ET9002.505
11:52 ET1002.51
11:54 ET2662.5101
11:56 ET6002.53
11:57 ET13002.53
11:59 ET5842.53
12:01 ET4432.52
12:08 ET1002.511
12:10 ET25222.5101
12:12 ET7852.51
12:14 ET6002.5094
12:17 ET2002.5097
12:19 ET1002.5
12:24 ET34452.51
12:28 ET18002.5079
12:30 ET6002.51
12:32 ET1002.5
12:33 ET6002.5
12:37 ET34662.5099
12:39 ET13692.5
12:42 ET4002.5
12:44 ET50812.46
12:46 ET2662.485
12:48 ET24202.47
12:50 ET6502.4527
12:53 ET3152.47
12:55 ET1002.47
12:57 ET54172.49
01:00 ET1002.49
01:02 ET2002.51
01:04 ET5002.49
01:06 ET1002.52
01:08 ET3092.52
01:09 ET1002.52
01:11 ET3322.51
01:18 ET1002.52
01:22 ET1132.5102
01:26 ET1002.53
01:27 ET1002.53
01:31 ET7002.51
01:38 ET10002.53
01:40 ET3252.54
01:42 ET29262.5485
01:44 ET46852.54
01:47 ET5282.5373
01:51 ET2002.55
01:54 ET1002.555
01:56 ET1002.57
01:58 ET3162.57
02:02 ET1002.58
02:03 ET1002.56
02:05 ET7002.56
02:14 ET2002.53
02:18 ET1012.5325
02:21 ET1072.5301
02:25 ET1002.55
02:30 ET1002.56
02:34 ET6962.5401
02:36 ET5182.53
02:41 ET29652.54
02:43 ET1002.52
02:45 ET11502.51
02:50 ET14702.5
02:52 ET1002.4822
02:54 ET1002.47
02:59 ET7452.445
03:03 ET53642.4614
03:06 ET39302.475
03:08 ET15202.4626
03:10 ET66612.45
03:12 ET30002.448
03:14 ET2542.47
03:15 ET5002.4336
03:26 ET3992.48
03:30 ET1002.485
03:33 ET63152.46
03:35 ET11002.475
03:42 ET4002.48
03:44 ET5002.48
03:46 ET1002.47
03:48 ET26002.46
03:50 ET73772.44
03:51 ET5002.4437
03:53 ET31492.45
03:55 ET11892.44
03:57 ET5852.435
04:00 ET38302.43
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPXMD
PaxMedica Inc
29.2M
-8.5x
---
United StatesPPBT
Purple Biotech Ltd
29.1M
-0.1x
---
United StatesEDSA
Edesa Biotech Inc
28.6M
-1.2x
---
United StatesGWLL
Goldenwell Biotech Inc
28.3M
-286.4x
---
United StatesAGE
AgeX Therapeutics Inc
29.8M
-3.0x
---
United StatesLUMO
Lumos Pharma Inc
28.9M
-1.0x
---
As of 2023-01-28

Company Information

PaxMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Its product candidates include PAX-101 and PAX-102. Its lead program, PAX-101, is an intravenous formulation of suramin, in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders, such as ME/CFS and Long COVID-19 Syndrome (LCS). It is also focused on developing PAX-101 for the treatment of East African Human-African Trypanosomiasis (HAT), which is caused by the parasite Trypanosome brucei rhodesiense. It is also focused on developing PAX-102, which is an intranasal formulation of suramin for neurologic indications.

Contact Information

Headquarters
303 South Broadway, Suite 125TARRYTOWN, NY, United States 10591
Phone
914-987-2876
Fax
302-636-5454

Executives

Executive Chairman of the Board
Michael Derby
Chief Executive Officer, Director
Howard Weisman
Chief Financial Officer
Stephen Sheldon
Chief Operating Officer, Director
Zachary Rome
Independent Director
Charles Casamento

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$29.2M
Revenue (TTM)
$0.00
Shares Outstanding
12.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.28
Book Value
$-0.86
P/E Ratio
-8.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.